GN Store Nord A/S
GN Store Nord A/S provides hearing, audio, video, and gaming solutions in Denmark, Europe, North America, and internationally. The company operates through Hearing, Enterprise, and Gaming segments. The Hearing segment produces and sells hearing instruments and products. The Enterprise segment supplies audio and video devices for professional use. The Gaming segment produces gaming devices and per… Read more
GN Store Nord A/S (GGNDF) - Net Assets
Latest net assets as of December 2025: $10.87 Billion USD
Based on the latest financial reports, GN Store Nord A/S (GGNDF) has net assets worth $10.87 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($29.16 Billion) and total liabilities ($18.29 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $10.87 Billion |
| % of Total Assets | 37.29% |
| Annual Growth Rate | 5.32% |
| 5-Year Change | 74.56% |
| 10-Year Change | 93.48% |
| Growth Volatility | 13.18 |
GN Store Nord A/S - Net Assets Trend (2012–2025)
This chart illustrates how GN Store Nord A/S's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for GN Store Nord A/S (2012–2025)
The table below shows the annual net assets of GN Store Nord A/S from 2012 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $10.87 Billion | +0.46% |
| 2024-12-31 | $10.82 Billion | +12.90% |
| 2023-12-31 | $9.59 Billion | +40.99% |
| 2022-12-31 | $6.80 Billion | +9.17% |
| 2021-12-31 | $6.23 Billion | +20.30% |
| 2020-12-31 | $5.18 Billion | +6.78% |
| 2019-12-31 | $4.85 Billion | -4.85% |
| 2018-12-31 | $5.10 Billion | +6.54% |
| 2017-12-31 | $4.78 Billion | -14.89% |
| 2016-12-31 | $5.62 Billion | -2.50% |
| 2015-12-31 | $5.76 Billion | +1.71% |
| 2014-12-31 | $5.67 Billion | +6.32% |
| 2013-12-31 | $5.33 Billion | -3.83% |
| 2012-12-31 | $5.54 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to GN Store Nord A/S's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 163.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $14.24 Billion | 130.97% |
| Common Stock | $602.63 Million | 5.54% |
| Other Comprehensive Income | $-1.25 Billion | -11.51% |
| Total Equity | $10.87 Billion | 100.00% |
GN Store Nord A/S Competitors by Market Cap
The table below lists competitors of GN Store Nord A/S ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
OSB Group Plc
PINK:OSBGF
|
$2.18 Billion |
|
Sacyr SA
MC:SCYR
|
$2.19 Billion |
|
Ashland Global Holdings Inc
NYSE:ASH
|
$2.19 Billion |
|
Figs Inc
NYSE:FIGS
|
$2.19 Billion |
|
UCloud Technology Co Ltd
SHG:688158
|
$2.18 Billion |
|
Advanced Echem Materials Company Limited
TWO:4749
|
$2.18 Billion |
|
Alarm.com Holdings Inc
NASDAQ:ALRM
|
$2.18 Billion |
|
Kalmar
HE:KALMAR
|
$2.18 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GN Store Nord A/S's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 10,824,000,000 to 10,873,315,000, a change of 49,315,000 (0.5%).
- Net income of 651,520,919 contributed positively to equity growth.
- Dividend payments of 85,000,000 reduced retained earnings.
- Other comprehensive income decreased equity by 1,251,160,000.
- Other factors increased equity by 733,954,081.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $651.52 Million | +5.99% |
| Dividends Paid | $85.00 Million | -0.78% |
| Other Comprehensive Income | $-1.25 Billion | -11.51% |
| Other Changes | $733.95 Million | +6.75% |
| Total Change | $- | 0.46% |
Book Value vs Market Value Analysis
This analysis compares GN Store Nord A/S's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.20x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.44x to 0.20x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | $34.27 | $15.00 | x |
| 2013-12-31 | $31.56 | $15.00 | x |
| 2014-12-31 | $34.64 | $15.00 | x |
| 2015-12-31 | $36.78 | $15.00 | x |
| 2016-12-31 | $37.88 | $15.00 | x |
| 2017-12-31 | $34.17 | $15.00 | x |
| 2018-12-31 | $37.51 | $15.00 | x |
| 2019-12-31 | $36.63 | $15.00 | x |
| 2020-12-31 | $39.82 | $15.00 | x |
| 2021-12-31 | $47.84 | $15.00 | x |
| 2022-12-31 | $53.07 | $15.00 | x |
| 2023-12-31 | $68.98 | $15.00 | x |
| 2024-12-31 | $74.28 | $15.00 | x |
| 2025-12-31 | $74.62 | $15.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently GN Store Nord A/S utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.99%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.87%
- • Asset Turnover: 0.58x
- • Equity Multiplier: 2.68x
- Recent ROE (5.99%) is below the historical average (15.75%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 5.19% | 5.14% | 0.76x | 1.32x | $-298.00 Million |
| 2013 | 13.79% | 10.82% | 0.76x | 1.68x | $202.00 Million |
| 2014 | 13.99% | 10.80% | 0.72x | 1.81x | $226.30 Million |
| 2015 | 13.97% | 10.38% | 0.69x | 1.94x | $228.60 Million |
| 2016 | 18.38% | 11.94% | 0.67x | 2.28x | $471.00 Million |
| 2017 | 23.46% | 11.71% | 0.82x | 2.45x | $643.70 Million |
| 2018 | 24.35% | 11.70% | 0.81x | 2.55x | $731.40 Million |
| 2019 | 29.99% | 11.56% | 0.75x | 3.44x | $969.10 Million |
| 2020 | 24.18% | 9.31% | 0.81x | 3.22x | $734.20 Million |
| 2021 | 28.19% | 11.13% | 0.67x | 3.78x | $1.13 Billion |
| 2022 | 7.51% | 2.73% | 0.61x | 4.50x | $-169.00 Million |
| 2023 | 2.38% | 1.26% | 0.59x | 3.20x | $-730.70 Million |
| 2024 | 9.13% | 5.49% | 0.59x | 2.83x | $-94.40 Million |
| 2025 | 5.99% | 3.87% | 0.58x | 2.68x | $-435.81 Million |
Industry Comparison
This section compares GN Store Nord A/S's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GN Store Nord A/S (GGNDF) | $10.87 Billion | 5.19% | 1.68x | $2.18 Billion |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |